WASHINGTON (Reuters) - Cholesterol-lowering drugs do not raise or lower the risk of cancer, researchers said on Tuesday in two new reports that challenge earlier findings suggesting statins may prevent certain cancers.
Researchers at the University of Connecticut analyzed 26 previous studies involving 87,000 total patients, but concluded the blockbuster drugs had no cancer impact, according to their report published in the Journal of the American Medical Association.